biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by Boomskidon Apr 13, 2023 7:17pm

183 Views

Post# 35394213

A Small Point...

Daniel Carlson, stock promoter, owner of Tailwinds, "accuses" me of causing people to buy and hold Bioasis shares.

Of course, Daniel Carlson is a stock promoter, which means that his job is to convince people to buy and hold his clients' shares. That's what he accuses me of doing. He didn't do it too well with Bioasis. Bioasis didn't keep around for long.

So, he's accusing me of being a success at his job, at what he was paid to do but failed at.

So, what's the answer, Danny? Sometime down the road, if you become successful as a stock promoter, it seems that you won't know whether to be proud or critical of your accomplishment.

Weird...

jd

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload